Edition:
United States

Grifols SA (GRFS.OQ)

GRFS.OQ on NASDAQ Stock Exchange Global Select Market

21.46USD
4:00pm EDT
Change (% chg)

$0.07 (+0.33%)
Prev Close
$21.39
Open
$21.40
Day's High
$21.59
Day's Low
$21.34
Volume
178,282
Avg. Vol
186,594
52-wk High
$25.17
52-wk Low
$19.92

Chart for

About

No overview information found for .

Overall

No Ratios Available.

Financials

  GRFS.OQ Industry Sector
P/E (TTM): -- 29.26 33.20
EPS (TTM): -- -- --
ROI: -- 13.66 13.23
ROE: -- 15.51 15.28

Spanish stocks - Factors to watch on Friday

The following Spanish stocks may be affected by newspaper reports and other factors on Firday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

May 25 2018

BRIEF-Grifols Expands Its Blood Typing Solutions Portfolio In US With Antisera Reagents

* GRIFOLS EXPANDS ITS BLOOD TYPING SOLUTIONS PORTFOLIO IN THE UNITED STATES WITH ANTISERA REAGENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

May 14 2018

BRIEF-Grifols Q1 EBITDA Down 2.8 Pct At 297 Mln Euros YoY

* Q1 EBITDA 297.4 MILLION EUROS VERSUS 306.0 MILLION EUROS YEAR AGO

May 03 2018

BRIEF-Grifols Concludes Experimental Phase Of Clinical Trial On Alzheimer

* SAYS CONCLUDES EXPERIMENTAL PHASE OF AMBAR, A CLINICAL TRIAL ON ALZHEIMER'S DISEASE

Mar 22 2018

BRIEF-Grifols To Buy German Pharmaceutical Company Haema For 220 Mln Euros

* SAYS REACHES DEAL WITH ATON GMBH TO BUY 100 PERCENT OF HAEMA AG FOR 220 MILLION EUROS ON A DEBT FREE BASIS ‍​ Source text for Eikon:

Mar 20 2018

Spanish stocks - Factors to watch on Wednesday

The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

Mar 14 2018

BRIEF-Grifols Announces New Agreement With Henry Schein To Distribute Normal Saline Solution In U.S.

* GRIFOLS - ANNOUNCES NEW AGREEMENT WITH HENRY SCHEIN TO DISTRIBUTE NORMAL SALINE SOLUTION IN THE U.S.

Mar 05 2018

Spanish stocks - Factors to watch on Wednesday

The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

Feb 28 2018

BRIEF-Grifols FY Net Profit Up At 662.7 Mln Euros

* FY NET SALES 4.32 BILLION EUROS VERSUS 4.05 BILLION EUROS YEAR AGO

Feb 28 2018

BRIEF-Grifols Receives FDA Approval For New Formulation Of Its Rabies Virus Treatment

* GRIFOLS HYPERRAB® (RABIES IMMUNE GLOBULIN) 300 IU/ML RECEIVES FDA APPROVAL TO TREAT PATIENTS EXPOSED TO RABIES VIRUS INFECTION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 06 2018

Earnings vs. Estimates